Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
Image Credit: Swisscore Announcement Gain Therapeutics Inc., a leading clinical-level biotechnology company known for its development and exploratory-based next generation of allosteric smal...
Image Credit: Medical Device Network Announcement Smith+Nephew, the leading medical technology business, is proud to introduce its new data created by Professor Amit Gefen and his research t...
Image Credit: Bial Announcement Bial, a leading innovation-centric biopharmaceutical company targeting rare diseases and neurosciences, proudly mentioned its key progress in its current ACTI...
Image Credit: Drug Discovery and Development Announcement OS Therapies Inc., a leading antibody drug conjugate and clinical-stage cancer immunotherapy biotechnology company has informed a regulato...
Image Credit: Pancreatic Cancer Action Network Announcement Oncolytics Biotech Inc., a leading clinical-stage immunotherapy company, is establishing pelareorep, which has prompted an update on its...
Image Credit: Indian Pharma Post Announcement AbbVie, a leading biotech company, has proceeded with its submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for ...
Image Credit: Symbiosys Capital Management Announcement The Clene Inc., and its fully owned subsidiary Clene Nanomedicine Inc., a leading clinical stage biopharmaceutical company that targets mito...
Image Credit: India Pharma Outlook Announcement Sandoz, a known leader in producing affordable medicines, has entered the US with its generic iron sucrose injection with the approval of the US Foo...
Image Credit: Ncardia Announcement Ncardia, a known face in stem cell-related solutions for drug safety assessment and discovery, launched ncyte NHP-C vCardiomyocytes, the first ever available ven...
Announcement The US Food and Drug Administration (FDA) has granted Sanofi’s SAR446268 a fast-track designation. It is Sanofi’s one-time AAV gene therapy for non-congenital (adult and ju...
Speak with a healthcare analyst about your research, consulting, or platform needs.